Ignite Creation Date:
2024-05-06 @ 6:02 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05528952
Status:
RECRUITING
Last Update Posted:
2023-11-13
First Post:
2022-09-01
Brief Title:
Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Sponsor:
Centre Hospitalier Universitaire de Besancon
Organization:
Centre Hospitalier Universitaire de Besancon
Organization Data
Organization:
Centre Hospitalier Universitaire de Besancon
Class:
OTHER
Study ID:
2022680
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| PRODIGE | UNKNOWN |
| GERCOR - Multidisciplinary Oncology Cooperative Group | OTHER |